Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Philippe Erard, François Robert-Grandpierre, Pierre Kaeser 
Philippe Brouqui, Didier Raoult, Jean Marc Durand 
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy  S. Bertschy,
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Atypical respiratory pathogens
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Hydatid disease Clinical Microbiology and Infection
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility  Javier Garau, Walter Wilson,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Cephalosporins: a pharmacological update
Retrospective study of CMV retinitis in patients with AIDS
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Sepsis and neutropenia induced by clozapine
Uncommon opportunistic fungi: new nosocomial threats
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
A. Bryskier  Clinical Microbiology and Infection 
Community-acquired pneumonia: epidemiologic and clinical consideration
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Training in infectious diseases and tropical medicine in Britain
Fibronectin concentrations in catheter sepsis
Clinical infection services—the Leiden experience
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Empiric therapy of bacterial infections in severe neutropenia
Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis  José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.
Overview of cefixime use in community-acquired infections
Brita Bruun, Henrik Westh, Jørgen Stenderup 
The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece  J. Papaparaskevas, J. Stefanou, A. Vatopoulos,
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
D.L. Monnet, T.L. Sørensen  Clinical Microbiology and Infection 
Are we losing the fight against malaria one more time?
Three years experience of real-time PCR for the diagnosis of Q fever
N.C. Weightman, S. Mitra, P.T. Kipling 
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Pharmacokinetics of once-daily amikacin in pediatric patients
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Comparative study of pediculicidal effect of medical plants
Localized Mycobacterium avium complex infection in a patient on HAART
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine  Philippe Sudre, Jean Philippe Chave, Christian Ruef, Anne Iten, Heiner C. Bucher, Pietro L. Vernazza, Hansjakob Furrer, Enos Bernasconi, Norberto Ceserani, Manuel Battegay, Jan Von Overbeck, Ignazio Cassis, Adriano Lazzarin, Victor Gabriel, Bernard J. Hirschel  Clinical Microbiology and Infection  Volume 3, Issue 6, Pages 629-633 (December 1997) DOI: 10.1111/j.1469-0691.1997.tb00469.x Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Incidence of AIDS defining clinical events and death (Cox proportional hazard model). Clinical Microbiology and Infection 1997 3, 629-633DOI: (10.1111/j.1469-0691.1997.tb00469.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.